title: ICoVax 2013: the 3rd ISV Pre-conference Computational Vaccinology Workshop.
abstract: Following last year's computational vaccinology workshop in Shanghai, China, the third ISV Pre-conference Computational Vaccinology Workshop (ICoVax 2013) was held in Barcelona, Spain. ICoVax 2013 provided an international platform for the attendees to showcase their research and discuss problems and solutions in the development and application of computational vaccinology and vaccine informatics tools. The first of the three full-length papers presented at ICoVax discussed the discovery of viral "camouflage" through cross-conservation of T-cell epitopes using a tool called JanusMatrix. This important paper reports that viruses may camouflage their presence in the human body by incorporating sequences in their proteins that are highly cross-conserved at the T-cell receptor surface with human genome proteins, a discovery that has wide ranging implications for the development of vaccines against viruses that use the camouflage method. The other papers described a database for storing experimentally verified data on DNA vaccines and compared therapeutic targets of western drugs to Chinese herbal medicines for cardiovascular diseases. The short poster presentations covered various uses of informatics tools for processing the DNA and microRNA of pathogens to improve vaccine coverage, efficacy and development. A live (on-line) demonstration of the vaccine design toolkit, iVax, presented by Frances Terry of EpiVax, illustrated how computational vaccinology could be used in the design of next generation vaccines.
authors.forename: Anne S
authors.initials: AS
authors.lastname: De Groot
authors.forename: Phoebe
authors.initials: P
authors.lastname: De Groot
authors.forename: Yongqun
authors.initials: Y
authors.lastname: He
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy; D002681:China; D019295:Computational Biology / Q000193:education* / Q000379:methods*; D030561:Databases, Nucleic Acid; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D015894:Genome, Human; D006801:Humans; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology; D014764:Viral Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000737:chemistry / Q000276:immunology*; D014777:Virus Diseases / Q000276:immunology / Q000517:prevention & control; D014780:Viruses / Q000276:immunology
chemical_list: D004365:Drugs, Chinese Herbal; D018984:Epitopes, T-Lymphocyte; D011948:Receptors, Antigen, T-Cell; D019444:Vaccines, DNA; D014764:Viral Proteins; D014765:Viral Vaccines
references.citation: BMC Bioinformatics. 2014;15 Suppl 4:S2
references.pmid: 25104313
references.citation: BMC Bioinformatics. 2013;14 Suppl 4:I1
references.pmid: 23514034
references.citation: BMC Bioinformatics. 2014;15 Suppl 4:S1
references.pmid: 25104221
references.citation: Hum Vaccin Immunother. 2013 Jul;9(7):1577-86
references.pmid: 23584251
references.citation: Hum Vaccin Immunother. 2014;10(8):2366-77
references.pmid: 25424944
references.citation: BMC Bioinformatics. 2014;15 Suppl 4:S3
references.pmid: 25104437
references.citation: Hum Vaccin Immunother. 2013 May;9(5):950-6
references.pmid: 23807079
references.citation: Hum Vaccin Immunother. 2013 Sep;9(9):1877-84
references.pmid: 23877094